GTHX - G1 Therapeutics Inc
IEX Last Trade
7.11
0 0%
Share volume: 1,146,615
Last Updated: Fri 30 Aug 2024 09:59:56 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$7.11
0.00
0.00%
Summary score
25%
Profitability
25%
Dept financing
3%
Liquidity
50%
Performance
25%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-14.67%
Return on assets
-12.31%
Return on sales
0%
Return on invested capital
274.5%
Total debt ratio
9.26%
Debt ratio change over timeo
-0.97%
Current Ratio
16.16%
Quick Ratio
0%
Cash Position Ratio
16.25%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-13.5%
Return on assets
-12.03%
Return on sales
0%
Return on invested capital
497.57%
Total debt ratio
12.56%
Debt ratio change over timeo
-0.97%
Current Ratio
13.04%
Quick Ratio
0%
Cash Position Ratio
12.9%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-15.31%
Return on assets
-12.15%
Return on sales
0%
Return on invested capital
370.75%
Total debt ratio
19.62%
Debt ratio change over time
-0.97%
Current Ratio
10.95%
Quick Ratio
0%
Cash Position Ratio
10.69%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-105.31%
Return on assets
-105.02%
Return on sales
0%
Return on invested capital
9.79%
Total debt ratio
-96.51%
Debt ratio change over time
-0.97%
Current Ratio
7.43%
Quick Ratio
0%
Cash Position Ratio
7.42%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | GTHX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -14.67% | -3.05% | 11.55% | 6.27% |
| Return on assets | -12.31% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 274.5% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 37% | 68% | 59% |
| Total debt ratio | 9.26% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.97% | 6.09% | 6.03% | 1.53% |
| Dept financing | 2% | 50% | 43% | 14% |
| Current Ratio | 13.04% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 12.9% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 14% | 31% | 31% |
| Short-term ratios | GTHX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -13.5% | -25.62% | 17.94% | 7.14% |
| Return on assets | -12.03% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 497.57% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 39% | 70% | 58% |
| Total debt ratio | 12.56% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.97% | -23.44% | 9.66% | 0.6% |
| Dept financing | 3% | 25% | 45% | 8% |
| Current Ratio | 13.04% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 12.9% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 24% | 20% | 35% |